An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. BACKGROUND: Chronic kidney disease is a common comorbid condition among persons living with human immunodeficiency vi...
Saved in:
Main Authors: | Edgar T. Overton, Amy Kantor, Kathleen V. Fitch, Paul Muntner, Khuanchai Supparatpinyo, Mosepele Mosepele, Lerato Mohapi, Sandra Wagner Cardoso, Sandesh Patil, Marcus V.G. de Lacerda, Grace McComsey, Judith A. Aberg, Pamela S. Douglas, Steven K. Grinspoon, Heather Ribaudo, Christina M. Wyatt |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087843455&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70805 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
The Reprieve
by: Lara, Susan S.
Published: (1985) -
Meta-analysis of the comparative efficacy and safety of pitavastatin and atorvastatin in patients with dyslipidaemia
by: Nalinee Poolsup, et al.
Published: (2018) -
Effects of pitavastatin on lipid profiles in HIV-infected patients with dyslipidemia and receiving atazanavir/ritonavir: A randomized, double-blind, crossover study
by: Asita Wongprikorn, et al.
Published: (2018) -
Comparative efficacy and safety of pitavastatin 1 MG once daily dose versus atorvastatin 10 MG once daily dose in outpatients with hypercholesterolemia
by: Pawat Putwai
Published: (2012) -
Effects of pitavastatin on atherosclerotic-associated inflammatory biomarkers in people living with HIV with dyslipidemia and receiving ritonavir-boosted atazanavir: a randomized, double-blind, crossover study
by: Srichatrapimuk S.
Published: (2023)